Work

Methodological considerations for interpreting ketamine-naltrexone trials in depression

Year: 2025

Type: article

Abstract: Igor D Bandeira, MD, PhD, Luke A Jelen, MD, PhD, Jason M Tucciarone, MD, PhD, Boris D Heifets, MD, PhD, Carolyn I Rodriguez, MD, PhD, Alan F Schatzberg, MD

Source: The International Journal of Neuropsychopharmacology

DOI: 10.1093/ijnp/pyaf073

Authors: Igor D Bandeira, Luke A Jelen, Jason M Tucciarone, Boris D Heifets, Carolyn I Rodriguez, Alan F Schatzberg

Institutions: Stanford University, King's College London, South London and Maudsley NHS Foundation Trust, Stanford Medicine

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,693

Funder: National Institute on Drug Abuse

Award: A patch circuit dissection of opioid addiction

OpenAlex ID: W4414749300

FWCI: 2.406

Cites: 10

Cited by: 5

Related to: